Orbis International and Siloam Vision have deployed an AI system in Mongolia that helps non-specialist clinicians screen premature infants for retinopathy of prematurity, delivering results in seconds instead of days and catching a leading cause of preventable childhood blindness.
Foundation Health's AI system PAIGE is now automating refill processing, adherence outreach, and prior authorization at Intermountain Health's specialty pharmacy, part of a 2026 wave of AI tools aimed at pharmacy administrative work.
CareYaya's new QuikTok service lets isolated older adults have AI-powered conversations over an ordinary phone call, aiming to reduce loneliness and flag early signs of cognitive decline, with backing from AARP and Johns Hopkins.
A Johns Hopkins Wilmer Eye Institute study published in npj Digital Medicine found that African American patients with diabetes were far more likely to be referred for an eye exam when an AI-assisted retinal screening tool was used during a primary care visit.
Humana's new Agent Assist tool, built with Google Cloud's Gemini models, now supports more than 20,000 member advocates handling roughly 80 million calls a year, arriving as states pass new laws restricting AI's role in insurance coverage decisions.
ViField's Orioos robot, a spin-off of Portugal's INESC TEC, became commercially available to farmers in August 2026, scanning entire vineyards and orchards for disease instead of the roughly 10% sample size manual scouting typically covers.
A Harvard Medical School and Beth Israel Deaconess study published in Science found OpenAI's o1 model outdiagnosed emergency room physicians across six experiments, a result still fueling debate over AI's role in clinical care.
Massive Bio has been named an OpenAI Select Partner to expand its AI platform that matches cancer patients with clinical trials, converting dense trial eligibility criteria into structured data for faster review by oncologists.
Hackensack Meridian Health is the first U.S. health system to earn the Joint Commission's new Responsible Use of AI in Healthcare Certification, a governance credential that checks how hospitals oversee AI tools rather than approving any single algorithm.
Insilico Medicine has launched a Phase III trial of rentosertib, an AI-designed drug for idiopathic pulmonary fibrosis, making it one of the only AI-discovered therapeutics to reach late-stage trials as the industry still awaits its first full FDA approval.